Funder: Alzheimer's Association
Due Dates: February 16, 2026 (Letter of Intent; recurring monthly: LOIs due by the 15th or following Monday if on a weekend)
Funding Amounts: Bridge funding for 3–12 months; supports direct research costs and salary; travel capped at $7,000; indirect costs capped at 10%.
Summary: Provides interim support to early career researchers whose neurodegenerative disease projects have been disrupted by changes in federal funding.
Key Information: LOI required before full application; eligibility limited to Early Stage Investigators (NIH definition) with documented research disruption.